TO REPLY 1 COMMENT TO EACH POST WITH CITATION AND TWO REFERENCE EACH COMMENT APA ABOVE 2013.
POST 1
Three Questions for the Patient
After reviewing the material presented in this case study, there are some concerning questions regarding this patient’s psychiatric history. Additional questions would include:
After each discontinuation of medication after an episode of depression, was this decision the choice of a physician or self -initiated? This question would provide knowledge of the patient’s medication compliance. For example, does the patient stop taking prescribed medication on symptoms are alleviated?
What were the circumstances prior to each depressive episode? his question would enlighten the practitioner on triggers and factors that personally affect the patient before a depressive episode occurs.
There appears to be history of alcohol abuse and depression in your family, has anyone in your family received treatment? This question would provide a view into the patient’s understanding of psychiatric treatment. Since the patient does not believe in psychotherapy due to religious reason, the patient may not know what treatments were, are or will be available to him.
Feedback from People in Patient’s Life
The patient has been married for 33 years. Assuming his spouse is around before, during and after an episode, she may provide information the patient failed to share or may not have been honest about. The first person to be questioned would be the patient’s wife. Some of the questions for the patient’s wife would include onset of symptoms. What occurs before each episode of depression? Is there conflict between you and your spouse? Are there any stressors, such as financial plaguing your spouse and you?
The patient also has three children. All three of his children suffer from some form of depression. Questioning the patient’s children may provide a historical history of the patient. For example, the children may have noticed symptoms leading to the patient’s depression years ago. Questions for the children may include did your parent’s argue often while you were growing up? Did your father ever lose interest in your childhood years? Did you feel love or rejection while growing up from your father? What were your father’s behaviors? Did you ever notice any alcohol or drug abuse while growing up?
Physical and Diagnostic Exams for Patient
Unfortunately, there is not a certain test for depression. The primary goal of physical exam and diagnostic testing would to rule out other conditions causing similar symptoms. A physical exam should be preformed assessing respiratory and cardiovascular system. Vital signs should be taken as well.
Certain labs should be assessed in the patient. The practitioner should check the patient’s thyroid levels. Thyroid hormones have been linked to depression (Stahl, 2008). Depression can be caused by an underactive or overactive thyroid.
Another lab test to consider would be dexamethasone suppression test. This test assesses the negative affect of dexamethasone. Once given dexamethasone, in a small dose, cortisol levels are decreased in healthy adults, but may remain elevated in depressed patients (Smith, et al., 2013).
Depressive disorders have been linked to certain inflammatory biomarkers. This blood test assesses nine biomarkers, alpha-1 antitrypsin, apolipoprotein CIII, BDNF, cortisol, epidermal growth factor, myeloperoxidase, prolactin, resin, and soluble tumor necrosis factor α type II. These biomarkers represent the inflammatory and metabolic pathways associated with depression (Serra et al., 2015).
Three Differential Diagnosis
Based on the symptoms listed by the patient, there a multiple diagnosis this patient could be suffering from. Recurrent Major Depressive Disorder with melancholic features. This diagnosis is due to the patient’s major depressive symptoms, such as depressed mood most of the day, increased anxiety, and suicidal thoughts (Zaninotto et al., 2016). The specifier of melancholic features is based on the patient’s symptoms being worse in the morning, inability to function and lack of pleasure (Zaninotto et al., 2016). Other diagnoses for the is patient could be a thyroid imbalance or panic disorder
Two pharmacologic agents
Since this patient has become resistant to first line and second line drug therapy for depression, Phenelzine, an MAOI should be started for this patient. Phenelzine 45mg daily, divided into three doses throughout the day. Another suggestion for this patient would be Isocarboxazid. The dosage would start at 10mg BID, if tolerated the dosage could increase to another 10mg every 2-4 days until the dosage of 40 mg was achieved with tolerance. If therapeutic response is achieved, this medication should be slowly decreased without affecting therapeutic response (Arcangelo et al., 2013). Due to the pharmacokinetics and pharmacodynamics of Isocarboxazid, Phenelzine, should be prescribed to this patient. Since there is an increased to patients who have cardiac issues such as atrial fibrillation. The pharmacodynamics of Isocarboxazid are not clearly understood, but this may be due to the inhibition of MAO to the heart (Drugs, 2018).
MAOIs and Ethnicities
With many MAOIs, hypertensive crisis is a major concern for nay race. Since minorities are diagnosed with hypertension at higher rates, this causes a greater concern. This is the reason for a tyramine restricted diet. Foods such as aged chees, yeast and tap beer should be avoided ()
Changes in Therapy
After review of further data with this patient, changes would not be made to the suggested treatment.
Lessons Learned
Throughout this case study many lessons were present. The lesson of medication compliance was the first lesson learned. Another lesson learned was the lesson of proper medication selection in a patient, especially after a recurrent episode of depression. Assessment and presentation of psychiatric treatment for patients was another lesson learned from this case study.
Conclusion
In conclusion, this case study involved a 63-year-old male with recurrent depression. The patient has had success and failures with medication and treatment. These failures may be due to medication compliance or improper cessation of medications from a physician. After two years, the patient is finally on the right track. Hopefully, this will continue.
References
Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.
Drugs.com. (2018). Isocarboxazid. Retrieved from http:/ ttps://www.drugs.com/pro/marplan.html
Serra, F., Spoto, A., Ghisi, M., & Vidotto, G. (2015). Formal Psychological Assessment in Evaluating Depression: A New Methodology to Build Exhaustive and Irredundant Adaptive Questionnaires. PLoS ONE, 10(4), e0122131. http://doi.org/10.1371/journal.pone.0122131
Smith, K. M., Renshaw, P. F., & Bilello, J. (2013). The diagnosis of depression: current and emerging methods. Comprehensive Psychiatry, 54(1), 1–6. http://doi.org/10.1016/j.comppsych.2012.06.006
Stahl, S. M. (2008). Essential Psychopharmacology Online. Retrieved September 11, 2018 from
https://stahlonline-cambridge-org.ezp.waldenulibrary.org/prescribers_drug.jsf?
Zaninotto, L., Solmi, M., Veronese, N., Guglielmo, R., Ioime, L., Camardese, G., & Serretti, A. (2016). A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression. Journal of affective disorders, 201, 15-24.
POST 2
Three questions that I might ask our patient are:
- Tell me when you take your medication? [The reason for this question is to establish his adherence to his medication. Tachyphylaxis aka poop out, may occur due to medication nonadherence. It is therefore important to assess if the client is experiencing tachyphylaxis related to medication nonadherence] (Targum, 2014).
- Do you feel a lack of motivation about life? [The Rothschild Scale for Antidepressant Tachyphylaxis suggests a conceptualization of antidepressant tachyphylaxis that is characterized by symptoms of apathy.] (Targum, 2014).
- Are you experiencing patterns of sleep disturbance? [This is also a symptom of poop out. It is important to assess these symptoms in order to proceed with his plan of care. Another important question is to assess the client for is substance abuse which was already addressed within the case study.)
According to our case study, our client is a 69-year-old retired male who is married with children and grandchildren. In my opinion, it would be most important to speak to those that are the closest to him (his wife) who can observe him for any signs of activation of bipolar disorder such as: lack of impulse control, irritable and agitated mood lasting longer than a week (Bail, Dains, Flynn, Solomon, & Stewart, 2015). Activation of bipolar disorder would require his antidepressant to be discontinued and switched to a mood stabilizer (Stahl, 2013).
Physical exams and diagnostic tests relevant to our client’s care would be testing his blood pressure before/during initiating treatment and testing for plasma levels of O-desmethylvenlafaxine (ODV) which is an active metabolite of venlafaxine formed as a result of CYP450 2D6 (Stahl, 2013). Plasma levels of ODV will determine if the provider may safely increase his dose based on results. It is imperative to assess our client’s blood pressure related to the effects of the norepinephrine in the SNRI. Based on the check points for his first follow up, I would have changed his phone follow up to a face to face follow up to assess our client better and would have ordered his plasma ODV sooner to properly assess the effectiveness of his medication therapy.
According to the American Psychiatric Association (2013), three differential diagnoses that I am giving our client are: 1. mood disorder due to another medical condition 2. Sadness 3. Adjustment disorder with depressed mood. The one that I think is more likely is sadness. My thought is sadness because our client’s history from the case study reveals a long, waxing and waning major depressive episode where he feels like he is out of options (Stahl, 2013).
Two pharmacologic agents that would be appropriate for our client’s therapy would be Mirtazapine 15 mg PO nightly or Bupropion 75 mg PO BID. Bupropion is an NDRI which is a good augmenting combination with Venlafaxine. It is a powerful enhancer of noradrenergic action. Mirtazapine is a dual serotonin and norepinephrine combination which also works well with Venlafaxine but it may further increase his high cholesterol; for this reason, I would choose the Bupropion.
Lessons that I learned from this case study are certain drugs may not be as effective due to noncompliance, pharmacokinetic failures or even genetic variants. I have also learned the seriousness of how severe depression can be and the importance of knowing not necessarily all of the drugs out on the market for depression but more so the pharmacokinetics and pharmacodynamics of how they work.
Leonie
Reference
Targum, S. D. (2014). Identification and treatment of antidepressant tachyphylaxis. Innovations in Clinical Neuroscience, 11(24), 3-4. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008298/
Ball, J. W., Dains, J. E., Flynn, J. A., Solomon, B. S., & Stewart, R. W. (2015). Seidel’s guide to physical examination (8th ed.). St. Louis, MO: Elsevier Mosby.
Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. Retrieved from Walden Library databases.
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion Telehealth
/in Uncategorized /by developerHow does telehealth improve access to care for vulnerable populations and assist healthcare professionals in meeting the needs of this population? Discuss how access to telehealth services improves patient care and decreases health disparities.
Identify potential issues that could impact patient safety. Briefly discuss the effects of social media on our healthcare system in your response.
Identify examples of telehealth currently used in our healthcare system, citing your source. Please expand on the topic of telehealth by discussing its impact on improving access and patient safety. Do you agree with its use? Why or why not. Please explain.
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Aging Process 19474239
/in Uncategorized /by developerAs individuals grow older, they experience biological changes, but how they experience these changes varies considerably. Senescence, or the process of aging, “affects different people, and various parts of the body, at different rates” (Zastrow & Kirst-Ashman, 2019, p. 644).
What factors affect the aging process? Why do some individuals appear to age faster than others? In this Discussion you address these questions and consider how, you, as a social worker, might apply your understanding of the aging process to your work with older clients.
To prepare for this Discussion, read “Working With the Aging: The Case of Francine” in Social Work Case Studies: Foundation Year.
Working With the Aging: The Case of Francine
Francine is a 70-year-old, Irish Catholic female. She worked for 40 years as a librarian in an institution of higher education and retired at age 65. Francine has lived alone for the past year, after her partner, Joan, died of cancer. Joan and Francine had been together for 30 years, and while Francine personally identifies as a lesbian, she never came out to her family or to her colleagues. When speaking to all but her closest confidantes, Francine referred to Joan as her “best friend” or her “roommate.” Francine’s bereavement was therefore complicated because she did not feel she could discuss the true nature of her partnership with Joan. She felt that there was little recognition from her family, and even some of her close associates, of the impact and meaning of Joan’s death to Francine. There is a history of alcohol abuse in Francine’s family, and Francine abused alcohol from late adolescence into her mid-30s. However, Francine has been in recovery for several decades. Francine has no known sexual abuse history and no criminal history.
Francine sought counseling with me for several reasons, including an ongoing depressed mood, a lack of pleasure or enjoyment in her life, and loneliness and isolation since Joan’s death. She also reported that she had begun to drink again and that while her drinking was not yet at the level it had been earlier in her life, she was concerned that she could return to a dependence upon alcohol. Francine came to counseling with several considerable strengths, including a capacity to form intimate relationships, a successful work history, a history of having maintained her sobriety in the past for many years, as well as insight into the factors that had contributed to her current difficulties.
During our initial meetings, Francine stated that her goals were to feel less depressed, to reduce or stop drinking, and to feel less isolated. In order to ensure that no medical issues were contributing to her depression symptoms, I referred Francine to her primary care physician for an evaluation. Francine’s physician did not find any medical cause of her symptoms, diagnosing Francine with moderate clinical depression and recommending that Francine begin a course of antidepressant medication. Francine was reluctant to take medication and first wanted to try a course of counseling.
In order to help Francine meet her goal of reducing her depression symptoms, I employed a technique called behavioral activation (BA), which is drawn from principles of cognitive behavioral therapy and helps to reengage people in pleasant physical, social, and recreational activities. We began with a small initial goal of having Francine dedicate at least 5 minutes of each day to an activity she found pleasant or rewarding. Over the following weeks, we increased the time. Francine’s treatment progress was monitored through weekly completion of the Patient Health Questionnaire (PHQ-9) in order to determine whether or not her depressive symptoms were improving.
I helped Francine address her drinking by reconnecting her with effective coping strategies she had used in the past to achieve and maintain her sobriety. These included identifying triggers for the urge to drink and exploring her motivations for both continuing to drink and for stopping her use of alcohol. Francine began attending regular meetings of Alcoholics Anonymous™ (AA) and found several meetings that were specifically for older women and for lesbians. In addition, Francine spoke regularly with a sponsor who helped her to remain abstinent during particularly stressful moments during her reengagement in sobriety.
Finally, in order to address Francine’s goal of feeling less lonely and isolated, we explored potential avenues to increase her social networks. In addition to spending time with her family, friends, and her AA sponsor, Francine began to visit the local lesbian, gay, bisexual, and transgender (LGBT), center for the first time in her life and attended a support group for women who had lost their partners. Francine also began spending time at her local senior center and went there at least three times a week for exercise classes, other recreational activities, and lunch. She also began to do volunteer work at her local library once a week.
Over several months of counseling, Francine stopped drinking; significantly increased her daily involvement in pleasant and rewarding activities, including social and recreational activities; and reported feeling less lonely, despite still missing her partner a great deal. Francine’s scores on the PHQ-9 gradually decreased over time, and after 16 weeks of counseling, Francine reported that she no longer felt she needed the session to move on with her life. In addition, Francine visited her primary care physician, who found upon evaluation that her depression had lifted considerably and that an antidepressant was no longer indicated. By the end of counseling, Francine’s focused work on identifying her depression symptoms and her triggers for drinking equipped her to better recognize when she might need support in the future and to whom she could reach out for help if she needed it.
By Day 3
Post a Discussion in which you:
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Employers View
/in Uncategorized /by developerEmployers are making an effort to involve employees more in their health care. This is evidenced by the increase in consumer-directed health plans being offered by employers today. Employers feel that the more informed and engaged an employee is, the lower their health care costs will be. Employee engagement is a way for employers to battle rising health care costs and outlook on managed care plans.
What managed care trends do you think affect employers today and which do you think has the greatest impact on employers? Explain your perspective with examples. Do these trends impact small and large employers the same or not?
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Impact Of Ethnicity On Antidepressant Therapy 19461991
/in Uncategorized /by developerCase 1
The Case: The man whose antidepressants stopped working
The Question: Do depressive episodes become more difficult to treat and more recurrent over time?
The Dilemma: When can you stop antidepressant treatment and what do you do if medications that worked in the past no longer work?
Write a response to the following:
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Impact Of Ethnicity On Antidepressant Therapy
/in Uncategorized /by developerTO REPLY 1 COMMENT TO EACH POST WITH CITATION AND TWO REFERENCE EACH COMMENT APA ABOVE 2013.
POST 1
Three Questions for the Patient
After reviewing the material presented in this case study, there are some concerning questions regarding this patient’s psychiatric history. Additional questions would include:
After each discontinuation of medication after an episode of depression, was this decision the choice of a physician or self -initiated? This question would provide knowledge of the patient’s medication compliance. For example, does the patient stop taking prescribed medication on symptoms are alleviated?
What were the circumstances prior to each depressive episode? his question would enlighten the practitioner on triggers and factors that personally affect the patient before a depressive episode occurs.
There appears to be history of alcohol abuse and depression in your family, has anyone in your family received treatment? This question would provide a view into the patient’s understanding of psychiatric treatment. Since the patient does not believe in psychotherapy due to religious reason, the patient may not know what treatments were, are or will be available to him.
Feedback from People in Patient’s Life
The patient has been married for 33 years. Assuming his spouse is around before, during and after an episode, she may provide information the patient failed to share or may not have been honest about. The first person to be questioned would be the patient’s wife. Some of the questions for the patient’s wife would include onset of symptoms. What occurs before each episode of depression? Is there conflict between you and your spouse? Are there any stressors, such as financial plaguing your spouse and you?
The patient also has three children. All three of his children suffer from some form of depression. Questioning the patient’s children may provide a historical history of the patient. For example, the children may have noticed symptoms leading to the patient’s depression years ago. Questions for the children may include did your parent’s argue often while you were growing up? Did your father ever lose interest in your childhood years? Did you feel love or rejection while growing up from your father? What were your father’s behaviors? Did you ever notice any alcohol or drug abuse while growing up?
Physical and Diagnostic Exams for Patient
Unfortunately, there is not a certain test for depression. The primary goal of physical exam and diagnostic testing would to rule out other conditions causing similar symptoms. A physical exam should be preformed assessing respiratory and cardiovascular system. Vital signs should be taken as well.
Certain labs should be assessed in the patient. The practitioner should check the patient’s thyroid levels. Thyroid hormones have been linked to depression (Stahl, 2008). Depression can be caused by an underactive or overactive thyroid.
Another lab test to consider would be dexamethasone suppression test. This test assesses the negative affect of dexamethasone. Once given dexamethasone, in a small dose, cortisol levels are decreased in healthy adults, but may remain elevated in depressed patients (Smith, et al., 2013).
Depressive disorders have been linked to certain inflammatory biomarkers. This blood test assesses nine biomarkers, alpha-1 antitrypsin, apolipoprotein CIII, BDNF, cortisol, epidermal growth factor, myeloperoxidase, prolactin, resin, and soluble tumor necrosis factor α type II. These biomarkers represent the inflammatory and metabolic pathways associated with depression (Serra et al., 2015).
Three Differential Diagnosis
Based on the symptoms listed by the patient, there a multiple diagnosis this patient could be suffering from. Recurrent Major Depressive Disorder with melancholic features. This diagnosis is due to the patient’s major depressive symptoms, such as depressed mood most of the day, increased anxiety, and suicidal thoughts (Zaninotto et al., 2016). The specifier of melancholic features is based on the patient’s symptoms being worse in the morning, inability to function and lack of pleasure (Zaninotto et al., 2016). Other diagnoses for the is patient could be a thyroid imbalance or panic disorder
Two pharmacologic agents
Since this patient has become resistant to first line and second line drug therapy for depression, Phenelzine, an MAOI should be started for this patient. Phenelzine 45mg daily, divided into three doses throughout the day. Another suggestion for this patient would be Isocarboxazid. The dosage would start at 10mg BID, if tolerated the dosage could increase to another 10mg every 2-4 days until the dosage of 40 mg was achieved with tolerance. If therapeutic response is achieved, this medication should be slowly decreased without affecting therapeutic response (Arcangelo et al., 2013). Due to the pharmacokinetics and pharmacodynamics of Isocarboxazid, Phenelzine, should be prescribed to this patient. Since there is an increased to patients who have cardiac issues such as atrial fibrillation. The pharmacodynamics of Isocarboxazid are not clearly understood, but this may be due to the inhibition of MAO to the heart (Drugs, 2018).
MAOIs and Ethnicities
With many MAOIs, hypertensive crisis is a major concern for nay race. Since minorities are diagnosed with hypertension at higher rates, this causes a greater concern. This is the reason for a tyramine restricted diet. Foods such as aged chees, yeast and tap beer should be avoided ()
Changes in Therapy
After review of further data with this patient, changes would not be made to the suggested treatment.
Lessons Learned
Throughout this case study many lessons were present. The lesson of medication compliance was the first lesson learned. Another lesson learned was the lesson of proper medication selection in a patient, especially after a recurrent episode of depression. Assessment and presentation of psychiatric treatment for patients was another lesson learned from this case study.
Conclusion
In conclusion, this case study involved a 63-year-old male with recurrent depression. The patient has had success and failures with medication and treatment. These failures may be due to medication compliance or improper cessation of medications from a physician. After two years, the patient is finally on the right track. Hopefully, this will continue.
References
Arcangelo, V. P., Peterson, A. M., Wilbur, V., & Reinhold, J. A. (Eds.). (2017). Pharmacotherapeutics for advanced practice: A practical approach (4th ed.). Ambler, PA: Lippincott Williams & Wilkins.
Drugs.com. (2018). Isocarboxazid. Retrieved from http:/ ttps://www.drugs.com/pro/marplan.html
Serra, F., Spoto, A., Ghisi, M., & Vidotto, G. (2015). Formal Psychological Assessment in Evaluating Depression: A New Methodology to Build Exhaustive and Irredundant Adaptive Questionnaires. PLoS ONE, 10(4), e0122131. http://doi.org/10.1371/journal.pone.0122131
Smith, K. M., Renshaw, P. F., & Bilello, J. (2013). The diagnosis of depression: current and emerging methods. Comprehensive Psychiatry, 54(1), 1–6. http://doi.org/10.1016/j.comppsych.2012.06.006
Stahl, S. M. (2008). Essential Psychopharmacology Online. Retrieved September 11, 2018 from
https://stahlonline-cambridge-org.ezp.waldenulibrary.org/prescribers_drug.jsf?
Zaninotto, L., Solmi, M., Veronese, N., Guglielmo, R., Ioime, L., Camardese, G., & Serretti, A. (2016). A meta-analysis of cognitive performance in melancholic versus non-melancholic unipolar depression. Journal of affective disorders, 201, 15-24.
POST 2
Three questions that I might ask our patient are:
According to our case study, our client is a 69-year-old retired male who is married with children and grandchildren. In my opinion, it would be most important to speak to those that are the closest to him (his wife) who can observe him for any signs of activation of bipolar disorder such as: lack of impulse control, irritable and agitated mood lasting longer than a week (Bail, Dains, Flynn, Solomon, & Stewart, 2015). Activation of bipolar disorder would require his antidepressant to be discontinued and switched to a mood stabilizer (Stahl, 2013).
Physical exams and diagnostic tests relevant to our client’s care would be testing his blood pressure before/during initiating treatment and testing for plasma levels of O-desmethylvenlafaxine (ODV) which is an active metabolite of venlafaxine formed as a result of CYP450 2D6 (Stahl, 2013). Plasma levels of ODV will determine if the provider may safely increase his dose based on results. It is imperative to assess our client’s blood pressure related to the effects of the norepinephrine in the SNRI. Based on the check points for his first follow up, I would have changed his phone follow up to a face to face follow up to assess our client better and would have ordered his plasma ODV sooner to properly assess the effectiveness of his medication therapy.
According to the American Psychiatric Association (2013), three differential diagnoses that I am giving our client are: 1. mood disorder due to another medical condition 2. Sadness 3. Adjustment disorder with depressed mood. The one that I think is more likely is sadness. My thought is sadness because our client’s history from the case study reveals a long, waxing and waning major depressive episode where he feels like he is out of options (Stahl, 2013).
Two pharmacologic agents that would be appropriate for our client’s therapy would be Mirtazapine 15 mg PO nightly or Bupropion 75 mg PO BID. Bupropion is an NDRI which is a good augmenting combination with Venlafaxine. It is a powerful enhancer of noradrenergic action. Mirtazapine is a dual serotonin and norepinephrine combination which also works well with Venlafaxine but it may further increase his high cholesterol; for this reason, I would choose the Bupropion.
Lessons that I learned from this case study are certain drugs may not be as effective due to noncompliance, pharmacokinetic failures or even genetic variants. I have also learned the seriousness of how severe depression can be and the importance of knowing not necessarily all of the drugs out on the market for depression but more so the pharmacokinetics and pharmacodynamics of how they work.
Leonie
Reference
Targum, S. D. (2014). Identification and treatment of antidepressant tachyphylaxis. Innovations in Clinical Neuroscience, 11(24), 3-4. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4008298/
Ball, J. W., Dains, J. E., Flynn, J. A., Solomon, B. S., & Stewart, R. W. (2015). Seidel’s guide to physical examination (8th ed.). St. Louis, MO: Elsevier Mosby.
Stahl, S. M. (2013). Stahl’s essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). New York, NY: Cambridge University Press
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author. Retrieved from Walden Library databases.
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Inclusion Of Nurses In The Systems Development Life Cycle 19359729
/in Uncategorized /by developerIn the media introduction to this module, it was suggested that you as a nurse have an important role in the Systems Development Life Cycle (SDLC). With a focus on patient care and outcomes, nurses may not always see themselves as contributors to the development of new systems. However, as you may have observed in your own experience, exclusion of nurse contributions when implementing systems can have dire consequences.
In this Discussion, you will consider the role you might play in systems development and the ramifications of not being an active participant in systems development.
To Prepare:
Post a description of what you believe to be the consequences of a healthcare organization not involving nurses in each stage of the SDLC when purchasing and implementing a new health information technology system. Provide specific examples of potential issues at each stage of the SDLC and explain how the inclusion of nurses may help address these issues. Then, explain whether you had any input in the selection and planning of new health information technology systems in your nursing practice or healthcare organization and explain potential impacts of being included or not in the decision-making process. Be specific and provide examples.
APA 3 to 5 reference less than 5 years
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Inclusion Of Nurses In The Systems Development Life Cycle
/in Uncategorized /by developern the media introduction to this module, it was suggested that you as a nurse have an important role in the Systems Development Life Cycle (SDLC). With a focus on patient care and outcomes, nurses may not always see themselves as contributors to the development of new systems. However, as you may have observed in your own experience, exclusion of nurse contributions when implementing systems can have dire consequences.
In this Discussion, you will consider the role you might play in systems development and the ramifications of not being an active participant in systems development.
To Prepare:
Post a description of what you believe to be the consequences of a healthcare organization not involving nurses in each stage of the SDLC when purchasing and implementing a new health information technology system. Provide specific examples of potential issues at each stage of the SDLC and explain how the inclusion of nurses may help address these issues. Then, explain whether you had any input in the selection and planning of new health information technology systems in your nursing practice or healthcare organization and explain potential impacts of being included or not in the decision-making process. Be specific and provide examples.
References:
McGonigle, D., & Mastrian, K. G. (2017). Nursing informatics and the foundation of knowledge (4th ed.). Burlington, MA: Jones & Bartlett Learning.
Rurbic:
Excellent Good Fair Poor Main Posting Points Range: 45 (45%) – 50 (50%) Answers all parts of the discussion question(s) expectations with reflective critical analysis and synthesis of knowledge gained from the course readings for the module and current credible sources.
Supported by at least three current, credible sources.
Written clearly and concisely with no grammatical or spelling errors and fully adheres to current APA manual writing rules and style
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Post Will Be A Minimum Of 250 Words Make Sure You Provide Appropriate References And Utilize Apa Style Article And Rubric Are Attached
/in Uncategorized /by developerRead the attached article and analyze the identified benefits and consequences of applying the Theory of Integral Nursing to clinical practice. Discuss your analysis and identify the strengths and weaknesses of the scholarly article. Specify 2 MSN Essentials which most relate to the application of the Theory of Integral Nursing in clinical practice.
**Under the Class Resources tab, students will find the MSN Essentials which help to guide and shape graduate nursing education. Select 2 of these essentials that most closely reflect the concepts of the theory of integral nursing as instructed above.**
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Role Of Rnaprn In Policy Evaluation
/in Uncategorized /by developerIn the Module 4 Discussion, you considered how professional nurses can become involved in policy-making. A critical component of any policy design is evaluation of the results. How comfortable are you with the thought of becoming involved with such matters?
Some nurses may be hesitant to get involved with policy evaluation. The preference may be to focus on the care and well-being of their patients; some nurses may feel ill-equipped to enter the realm of policy and political activities. However, as you have examined previously, who better to advocate for patients and effective programs and polices than nurses? Already patient advocates in interactions with doctors and leadership, why not with government and regulatory agencies?
In this Discussion, you will reflect on the role of professional nurses in policy evaluation.
To Prepare:
Post an explanation of at least two opportunities that currently exist for RNs and APRNs to actively participate in policy review. Explain some of the challenges that these opportunities may present and describe how you might overcome these challenges. Finally, recommend two strategies you might make to better advocate for or communicate the existence of these opportunities. Be specific and provide examples.
4 to 4 References
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"
Discussion The Role Of The Nurse In Global Health
/in Uncategorized /by developerPlease read all instructions before accept the assignment. 350 words and all reference has scholar writers. APA format. This has to done by 1/7/20 by 8 pm
By Day 3
Post your analysis of one health problem between one developed and one developing country in comparison with the United States in terms of the WHO outcomes and criteria listed above. State your opinion about how well the United States is doing in terms of public health. Share what you think countries with worse outcomes could learn from countries with better outcomes. Explain the nurse’s role in public and global health and why nurses should be concerned with global health issues. Conclude by summarizing your view of the role of the nurse in public health.
Support your response with references from the professional nursing literature.
Note Initial Post: A 3-paragraph (at least 350 words) response. Be sure to use evidence from the readings and include in-text citations. Utilize essay-level writing practice and skills, including the use of transitional material and organizational frames. Avoid quotes; paraphrase to incorporate evidence into your own writing. A reference list is required. Use the most current evidence (usually ≤ 5 years old).
"Looking for a Similar Assignment? Get Expert Help at an Amazing Discount!"